Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate
Status:
Unknown status
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the response of erectile dysfunction in
hypogonadotrophic males with Testosterone undecanoate i.m. as per IIEF and the question of
the GAQ (Global Evaluation Questionnaire) after 42 weeks of treatment.
Secondary Study Objectives
- To monitor adverse events and changes in hemoglobin and serum chemistry with: PSA, lipid
profile, renal-hepatic profile and glycemia, and control by means of a rectal digital
examination.
- To Determinate physiologic reconstitution in patients under treatment by means of total
and free testosterone dosage.